October 23, 2026

Spyre Therapeutics, Inc. (SYRE)

⚠️ No article content returned.

..

Beta Bionics, Inc. (BBNX) Stock Analysis: A 25% Potential Upside Amidst Strong Revenue Growth

Beta Bionics, Inc. (NASDAQ: BBNX), a commercial-stage medical device company, is making waves in the healthcare sector with its innovative solutions designed to improve the lives..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Evaluating a 29.48% Upside Potential

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, presents a compelling investment case for those interested in the biotechnology sector. Specializing in novel therapeutics for..

Delcath Systems, Inc. (DCTH) Stock Analysis: Unveiling a 62.71% Potential Upside in the Medical Devices Sector

As investors search for promising opportunities within the healthcare sector, Delcath Systems, Inc. (NASDAQ: DCTH) stands out with a compelling potential upside of 62.71%, making it..

SI-BONE, Inc. (SIBN) Stock Analysis: 18% Potential Upside Backed by Strong Buy Ratings

SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the medical device sector, is drawing significant attention from investors due to its innovative solutions in the realm..

LifeMD, Inc. (LFMD) Stock Analysis: Potential Upside of 274.42% Captivates Investors

In the ever-evolving landscape of healthcare, LifeMD, Inc. (NASDAQ: LFMD) stands out as a compelling prospect for investors keen on capitalizing on the telehealth boom. With..

ArriVent BioPharma, Inc. (AVBP) Investor Outlook: Strong Buy Ratings and a Promising 16.15% Upside

ArriVent BioPharma, Inc. (AVBP), a rising star in the biotechnology sector, is capturing the attention of investors with its ambitious pipeline and a market cap of..

Savara, Inc. (SVRA) Stock Analysis: Exploring a 143% Upside Potential in Biotech

Savara, Inc. (SVRA), a promising player in the biotech sector, is capturing investor attention with its significant potential upside. The company, headquartered in Yardley, Pennsylvania, focuses..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unlocking a 42.94% Potential Upside in the Specialty Drug Market

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) has emerged as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..

uniQure N.V. (QURE) Stock Analysis: Investor Outlook Highlights 161% Potential Upside

uniQure N.V. (NASDAQ: QURE), a leading biotechnology firm based in the Netherlands, is making significant strides in the healthcare sector by focusing on gene therapies for..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Gem with 21.58% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) stands at the forefront of the biotechnology sector, offering a blend of innovation and potential that is capturing the attention of investors...

OrthoPediatrics Corp. (KIDS) Stock Analysis: Capturing Growth Potential with a 15.4% Revenue Surge

OrthoPediatrics Corp. (NASDAQ: KIDS), a leader in the pediatric orthopedic device sector, is making waves in the healthcare industry. With a focus on designing and marketing..

iRadimed Corporation (IRMD): Investor Outlook Reveals 34.64% Potential Upside for This Medical Device Innovator

iRadimed Corporation (NASDAQ: IRMD) stands out in the healthcare sector with its focus on MRI-compatible medical devices. As an innovator in this niche market, the company..

Oculis Holding AG (OCS) Stock Analysis: A Compelling 359% Upside Awaits Investors

Investors in the biotechnology sector may find Oculis Holding AG (NASDAQ: OCS) an intriguing opportunity with its remarkable potential upside. Based in Zug, Switzerland, Oculis is..

CorMedix Inc. (CRMD) Stock Analysis: Unpacking the Impressive 89.30% Potential Upside

Investors with a keen eye on the healthcare sector might want to take a closer look at CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company specializing in..

Enliven Therapeutics, Inc. (ELVN)

⚠️ No article content returned.

..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Unpacking a Potential 111.78% Upside

Arcus Biosciences, Inc. (NASDAQ: RCUS) stands as a noteworthy player in the biotechnology sector, specifically focusing on the development of innovative cancer therapies. With a market..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unpacking a Potential 379% Upside for Investors

Niagen Bioscience, Inc. (NASDAQ: NAGE) presents an intriguing opportunity for investors with its impressive potential upside of 379.50%, according to analyst ratings. Operating within the Consumer..

Evolus, Inc. (EOLS) Stock Analysis: A 102% Upside Potential in the Cosmetic Healthcare Sector

Evolus, Inc. (NASDAQ: EOLS) is catching the eyes of investors with a compelling potential upside of over 102%, according to recent analyst ratings. This performance beauty..

CeriBell, Inc. (CBLL) Stock Analysis: Strong Buy Ratings Signal Promising Growth in Medical Device Sector

CeriBell, Inc. (CBLL), a key player in the healthcare sector, is capturing investor attention with its innovative medical devices and a strong buy sentiment among analysts...

Search

Funds

October 23, 2026

Search

Funds

October 23, 2026

FTSE 100

Funds